Pesquisar este blog

Translate

quarta-feira, 5 de agosto de 2015

FDA Issues Final Guidance on Use of Nanomaterials in Food for Animals

The U.S. Food and Drug Administration has issued a final guidance for industry, “Use of Nanomaterials in Food for Animals,” which is intended to assist industry and other stakeholders in identifying potential issues related to safety or regulatory status of food for animals containing nanomaterials or otherwise involving the application of nanotechnology. This guidance is applicable to food ingredients intended for use in animal food which (1) consist entirely of nanomaterials, (2) contain nanomaterials as a component or (3) otherwise involve the application of nanotechnology.
This final guidance addresses the legal framework for adding nanomaterial substances to food for animals and includes recommendations for submitting a Food Additive Petition (FAP) for a nanomaterial animal food ingredient. This guidance also recommends manufacturers consult with FDA early in the development of their nanomaterial animal food ingredient and before submitting an FAP. At this time, we are not aware of any animal food ingredient engineered on the nanometer scale for which there is generally available safety data sufficient to serve as the foundation for a determination that the use of such an animal food ingredient is generally recognized as safe (GRAS).
Nanotechnology is an emerging technology that allows scientists to create, explore, and manipulate materials on a scale measured in nanometers – particles so small that they cannot be seen with a regular microscope. These particles can have chemical, physical, and biological properties that differ from those of their larger counterparts, and nanotechnology has a broad range of potential applications.
Guidance documents represent the FDA’s current thinking on particular topics, policies, and regulatory issues. While “guidance for industry” documents are prepared primarily for industry, they also are used by FDA staff and other stakeholders to understand the agency’s interpretation of laws and policies.
Although this guidance has been finalized, you can submit comments at any time. To submit comments to the docket by mail, use the following address. Be sure to include docket number FDA-2013-D-1009 on each page of your written comments.
Division of Dockets Management
HFA-305
Food and Drug Administration
5630 Fishers Lane, Room 1061
Rockville, MD 20852


Fonte: FDA

segunda-feira, 3 de agosto de 2015

NanoVacina: Pesquisa brasileira desenvolve NanoComprimido contra a hepatite B

O mercado de nanotecnologia está em franca expansão no mundo, com a descoberta de novos métodos e aplicações para os produtos desenvolvidos por meio desta técnica. O Brasil ainda não é uma das potências do ramo, mas produz pesquisas inovadoras sobre as utilizações desta tecnologia.

Por meio da nanomedicina, cientistas brasileiros estão próximos de desenvolver uma vacina via oral para prevenir a hepatite B - Foto: Secretaria de Saúde de Itajaí
Por meio da nanomedicina, cientistas brasileiros estão próximos de desenvolver uma vacina via oral para prevenir a hepatite B - Foto: Secretaria de Saúde de Itajaí

Uma delas é feita em uma parceria entre o Instituto Butantã e a Universidade de São Paulo (USP), que busca o desenvolvimento de uma vacina que pode ser administrada por via oral. Em vez de levar a famosa injeção ou as gotinhas pingadas nas bocas de bebês, será por meio de um comprimido que utiliza nanoestruturas de silício para guardar os antígenos. Atualmente, os testes são feitos apenas para prevenir a hepatite B.
A ideia nasceu de um encontro entre o infectologista Osvaldo Santana, do Butantã, e a física Márcia Fantini, do Laboratório de Cristalografia da USP. Durante a conversa, os cientistas começaram a traçar uma parceria para aliar as pesquisas em uma vacina contra a hepatite B e o desenvolvimento de uma sílica nanoestruturada para guardar os antígenos.
Com a estrutura em forma de favo de mel construída por meio de um longo processo de pesquisa e desenvolvimento, passou-se aos testes com camundongos, que apontaram resultados satisfatórios. A próxima etapa é provar a eficiência do método em seres humanos.
Na avaliação de Osvaldo Santana, a nova técnica tem amplas condições de se provar eficaz em humanos. Ele se baseia no fato de as nanoestruturas de sílica protegerem os antígenos da ação do sistema gástrico.
“Como ela protege a proteína, ela poderia proteger da barreira do suco gástrico, que é a barreira principal que você tem. A acidez do estômago e a protease, que são enzimas que quebram as proteínas, atacam a vacina. Toda vez que você tenta fazer a vacinação por via oral, você não consegue. Porque as proteínas são destruídas no estômago e não chegam no sistema imune, que está lá no intestino”, ressaltou Santana ao programa SP Pesquisa, da Univesp TV.
Outra vantagem apontada pelo pesquisador é que o invólucro de sílica garante que os antígenos atuem apenas nas “células alvo”. “A vantagem é que ela realmente consegue atravessar essa barreira de acidez muito forte do sistema imune”, completou.
Patente

Atualmente, a vacina via oral contra a hepatite B é produzida de forma experimental pelo laboratório Cristália, que financiou as pesquisas. A companhia já concedeu ao governo federal e ao governo do estado de São Paulo a patente para a produção da SBA-15 – o nome científico da nanoestrutura de sílica.


quinta-feira, 30 de julho de 2015

No Small Task: Generating Robust Nano Data

Used under creative commons license from brookhavenlab.
Visualizing and measuring materials at the nanoscale:
Center for Functional Nanomaterials at the Brookhaven National Laboratory.
A slogan that summarizes NGO and European Union Parliament requirements for regulating products of nanotechnology is “No data, no market.” But what kind of data and for what kind of market? I participated in a National Nanotechnology Initiative (NNI)/Consumer Products Safety Commission (CPSC) workshop, “Quantifying Exposure to Engineered Nanomaterials from Manufactured Products,” (QEEN) to get answers to those and related questions. The CPSC, whose budget was described by one of its officials as a “rounding error” relative to other NNI agencies’ budgets, co-organized an excellent workshop dedicated to producing data to protect consumers. According to both academic and regulatory scientist presentations at QEEN, it is no small task to generate reliable, good quality data to measure the exposure of humans, animals and the environment materials ranging from atomic to molecular-size that have been advertised as the basis for the 21st Century Industrial Revolution.

At the opening of QEEN, the pressure on the scientists to deliver the data to enable regulatory permits to commercialize nano-products was expressed by the assistant director of the presidential Office of Science and Technology Policy (OSTP). Dr. Lloyd Whitman said that fifteen years after the launch of the NNI, it was time for NNI 2.0, the era of nanotechnology commercialization. However, Dr. Whitman talked about how a new “ Environment, Health and Safety (EHS) ecosystem” with a faster throughput of data for evaluating risks would be needed. He announced an OSTP call for the scientists to pose (and later achieve) solutions to “Nanotechnology-Inspired Grand Challenges.” But first it would be necessary for the scientists to resolve the pesky problem of generating data.

The scientists identified three interrelated problems in generating data that reliably would inform regulators which nanomaterials in which products at what point in their life cycle would pose “unreasonable risks,” (a term in U.S. law) to consumers, workers and the environment. I found the three problems crucial to understanding exposures that could result from agri-nanotechnology products in the research and development pipeline, including nano-enabled pesticides, fertilizers and food packaging materials, for consumers, farm workers, rural communities and the environment.

First, to get realistic data about possible risks of nanotechnology-enabled products as they are used, it will be necessary to have the cooperation of nanotechnology product developers. The scientists must evaluate nanomaterials in their product matrix, e.g. nano silicon dioxide in a dry soup mix or nano titanium in sunscreen ointments. This kind of evaluation is a different, and more difficult, task than safety assessment of the pristine nanomaterials that scientists synthesized and studied during the first decade of the NNI.

However, that necessary cooperation by the nanotech industry has not been forthcoming, since there is no rule to compel it to submit nanotechnology-enabled products and data about those products for pre-market safety assessment. The scientists have had to resort to informal networks to get unofficial product samples, the risk assessment of which may have scientific validity but not regulatory validity, since the products have not been obtained with the cooperation of the product developer who seeks commercialization.

Second, many of the relevant experiments to simulate the “weathering,” or use of nano-enabled products over time, to obtain realistic exposure data often require expensive equipment and repeated trials. Sometimes such equipment is not available over the longer timeframe needed for exposure studies. Such practical considerations are crucial in determining how and how many nanoparticles are released from their product matrix, which, in turn, determines human and environmental exposure. But scientists do not yet understand what triggers particles to release under what conditions for many nanomaterials, so more experiments will be required to get realistic exposure data.

One academic scientist said that few commercial toxicology labs currently have the equipment and training to detect nanomaterials in products. How could their testing capacity be enhanced with less costly equipment than that used by government agencies and major research universities? One regulatory scientist indicated that currently there is no way to validate techniques for environmental modeling. This means there is data generated by experiments, but no database that will inform a lab reliably on the “fate and transport” of nanomaterials, i.e. where they will go and with what environmental, health and safety effects. There is an urgent need to publish the data sets, as well as the nanotechnology research papers funded by the government, so that scientists can mine the data sets outside their own research to be able to predict the environmental, health and safety effects of a nanotechnology application.

U.S. government funding has not been as forthcoming for exposure studies as it had been for determining nanomaterial hazards, such as unquantified potential for toxicity or mutagenicity. Another academic scientist said that he believed the use of carbon nanotubes (CNT) to strengthen polymers, such as those used in automobiles bumpers, could not become widespread without developing data to determine the effect of worker exposures to CNTs and to develop adequate protective equipment and manufacturing procedures to minimize risks to workers.

A third problem is that the anticipated increased complexity of nanomaterials and their multiple insertion points in products and the human and natural environment require a research strategy that groups similar materials for experimentation and risk assessment. There is scientific consensus, if not publicly available industry data, about which Top Ten nanomaterials are most widely used. However, there are no public databases that group nanomaterials on the basis of their electrical, chemical, magnetic, thermal and other properties, such as shape, particle distribution and other metrics.  Without such databases, regulator and industry demands for high throughput determination of environmental, health and safety effects cannot be realized. A smart industry would be happy to pay for such data bases as part of its sustainable business model.

The OSTP recommends that the EHS regulators evaluate each application for commercialization on a case by case basis, even if the EHS agency does not have the budget, infrastructure or personnel to do scientifically robust risk assessment on a scale. If the government and industry demanding the data are willing to pay for the experiments to generate it and the computer programming to organize the data into relatable groups, a product by product pre-market safety assessment is technically feasible.
However, in my view, the default procedure of inadequately resourced regulators under the current anti-regulatory siege in Congress likely will be to deregulate. Deregulation, in which neither industry nor the government is legally liable for product safety, may be an attractive alternative to trying to regulate product applications for which the agency lacks resources to conduct risk assessments on products based on robust exposure data of nanomaterials and nano-enabled products in realistic use simulations.
The science presented at QEEN was impressive in both its experimental design and ambition. While I cannot summarize the variety of experiments reported in a blog, nor, indeed, accurately report them in detail, some past NNI workshops have been reported on and included in some of the presentations, such as the recent report on the 2014 NNI workshop on nano-biosensors, in which IATP participated.

For example, it is now possible, as reported by Dr. Robert Mercer of the National Institute for Occupational Health and Safety, to visualize and count individual nanoparticles of different engineered nanomaterials in tissues sections samples from different sections of the lungs and lymph nodes of postmortem laboratory rats. After 12 days of inhalation exposure to Multi-Walled Carbon Nanotubes (MWCNTs), the agglomeration of MWCNTs can be visualized over a 336-day period in the lungs, lymph nodes, diaphragm, kidneys and brains of the exposed rats. Such experiments are crucial for determining the environmental, health and safety effects of MWCNTs and to designing industrial processes and protective equipment for those working with MWCNTs in an industrial setting.

Notwithstanding such an impressive experimental achievement in pathology, the technical limitations of  the life cycle modeling of how nanoparticles are transported in the air, water, blood, saliva and other fluids produce a wide range of uncertainty about data, e.g. for predictive toxicology. Variants of one scientist’s comment were repeated by many: despite a decade of research in life cycle modeling of nanomaterials, scientists still cannot respond to questions about human exposure assessment with the degree of precision and standardization required by regulators.  

There are nanotechnology jokes made about doing more with less, but if governments fail to finance adequately the research into human, animal and environmental exposures to nanomaterials, and if industry continues to fail to provide the scientists with nano-products to analyze in a regulatory process, regulators could allow a market for nanotechnology to develop without robust exposure data. The human and environmental health consequences of such a market, even if not resulting in acute toxicity, will not be funny at all.


Fonte: IATP

segunda-feira, 27 de julho de 2015

Nuevos medicamentos para detectar nanopartículas en los alimentos





La producción y la caracterización de materiales de referencia con los que detectar nanopartículas de plata en la carne es posible, tal y como se muestra en un experimento realizado recientemente. Los métodos empleados en el proyecto NANOLYSE consisten en la utilización de dos concentraciones distintas de nanopartículas de plata para adulterar carne de pollo y así generar materiales de referencia con los que detectar nanopartículas en alimentos.

Para la producción de los materiales de referencia se mezcló una suspensión acuosa de nanopartículas con puré de carne de pollo y el resultado se congeló a gran velocidad en nitrógeno líquido a -150 °C. Este procedimiento generó un material homogéneo con una aglomeración moderada de nanopartículas de plata. Gracias al experimento se descubrió que las dispersiones acuosas de nanopartículas de plata (AgNP) son lo suficientemente homogéneas como para servir de referencia. Aun así es necesario solventar ciertos obstáculos, como el concerniente a la evaluación de la estabilidad.

Los nanomateriales, que contienen partículas inferiores a los cien nanómetros, están encontrando cada vez más aplicaciones en ámbitos como la sanidad, la electrónica, los productos cosméticos, los embalajes, etc. Al mercado mundial de nanoproductos (productos que contienen nanomateriales) se le atribuye un valor de entre 150.000 y 200.000 millones de euros al año.

No obstante, las propiedades físicas y químicas de los nanomateriales difieren de las de esos mismos materiales en masa, por lo que es necesario realizar evaluaciones de riesgo específicas con las que garantizar su seguridad para los humanos y el medio ambiente. Esta es una tarea que se realiza en la actualidad para cada material, pero los métodos empleados han de actualizarse dada la popularización de estos materiales.

Además existen normativas jurídicas vigentes como el Reglamento (UE) 1169/2011 por el que se obliga a los productores de alimentos a informar a los consumidores sobre la presencia de nanopartículas artificiales. La presencia de nanopartículas en los alimentos es preocupante por el riesgo evidente de ingestión. Estas nanopartículas pueden contaminar los alimentos por filtración de aditivos del embalaje o por causas ambientales.

El proyecto NANOLYSE, Nanoparticles in Food: Analytical methods for detection and characterisation, activo desde enero de 2010 hasta septiembre de 2013, se dedicó a este tema. El proyecto se propuso desarrollar métodos validados y materiales de referencia para analizar nanopartículas en varios tipos de alimentos y bebidas. Los hallazgos de NANOLYSE contribuirán a garantizar la seguridad de las aplicaciones de los materiales con nanopartículas en contacto con los alimentos, por ejemplo los utilizados en el embalaje de alimentos, como los óxidos metálicos y los silicatos. En primer lugar se seleccionaron varias nanopartículas prioritarias que sirvieran de modelo de aplicabilidad de los métodos generados. Se dio prioridad a métodos que pudieran implementarse con facilidad en laboratorios de análisis de alimentos existentes. Los investigadores también desarrollaron programas informáticos para el análisis semiautomatizado de las imágenes de microscopia electrónica, que permite detectar nanopartículas en diferentes productos alimenticios de forma fiable.

Los métodos de detección y caracterización de nanopartículas en alimentos presentaban enormes carencias en el momento en el que se puso en marcha el proyecto NANOLYSE. En él propusieron varios métodos estándar posibles para la identificación rápida y fiable de nanopartículas sintéticas en alimentos, métodos que dos años después siguen sirviendo de base para nuevas investigaciones.


Fonte: NanoMed

domingo, 26 de julho de 2015

New study shows how nanoparticles can clean up environmental pollutants

Nanomaterials and UV light can “trap” chemicals for easy removal from soil and water.

Many human-made pollutants in the environment resist degradation through natural processes, and disrupt hormonal and other systems in mammals and other animals. Removing these toxic materials — which include pesticides and endocrine disruptors such as bisphenol A (BPA) — with existing methods is often expensive and time-consuming.
In a new paper published this week in Nature Communications, researchers from MIT and the Federal University of Goiás in Brazil demonstrate a novel method for using nanoparticles and ultraviolet (UV) light to quickly isolate and extract a variety of contaminants from soil and water.
Ferdinand Brandl and Nicolas Bertrand, the two lead authors, are former postdocs in the laboratory of Robert Langer, the David H. Koch Institute Professor at MIT’s Koch Institute for Integrative Cancer Research. (Eliana Martins Lima, of the Federal University of Goiás, is the other co-author.) Both Brandl and Bertrand are trained as pharmacists, and describe their discovery as a happy accident: They initially sought to develop nanoparticles that could be used to deliver drugs to cancer cells.
Brandl had previously synthesized polymers that could be cleaved apart by exposure to UV light. But he and Bertrand came to question their suitability for drug delivery, since UV light can be damaging to tissue and cells, and doesn’t penetrate through the skin. When they learned that UV light was used to disinfect water in certain treatment plants, they began to ask a different question.
“We thought if they are already using UV light, maybe they could use our particles as well,” Brandl says. “Then we came up with the idea to use our particles to remove toxic chemicals, pollutants, or hormones from water, because we saw that the particles aggregate once you irradiate them with UV light.”
A trap for ‘water-fearing’ pollution
The researchers synthesized polymers from polyethylene glycol, a widely used compound found in laxatives, toothpaste, and eye drops and approved by the Food and Drug Administration as a food additive, and polylactic acid, a biodegradable plastic used in compostable cups and glassware.
Nanoparticles made from these polymers have a hydrophobic core and a hydrophilic shell. Due to molecular-scale forces, in a solution hydrophobic pollutant molecules move toward the hydrophobic nanoparticles, and adsorb onto their surface, where they effectively become “trapped.” This same phenomenon is at work when spaghetti sauce stains the surface of plastic containers, turning them red: In that case, both the plastic and the oil-based sauce are hydrophobic and interact together.
If left alone, these nanomaterials would remain suspended and dispersed evenly in water. But when exposed to UV light, the stabilizing outer shell of the particles is shed, and — now “enriched” by the pollutants — they form larger aggregates that can then be removed through filtration, sedimentation, or other methods.
The researchers used the method to extract phthalates, hormone-disrupting chemicals used to soften plastics, from wastewater; BPA, another endocrine-disrupting synthetic compound widely used in plastic bottles and other resinous consumer goods, from thermal printing paper samples; and polycyclic aromatic hydrocarbons, carcinogenic compounds formed from incomplete combustion of fuels, from contaminated soil.
The process is irreversible and the polymers are biodegradable, minimizing the risks of leaving toxic secondary products to persist in, say, a body of water. “Once they switch to this macro situation where they’re big clumps,” Bertrand says, “you won’t be able to bring them back to the nano state again.”
The fundamental breakthrough, according to the researchers, was confirming that small molecules do indeed adsorb passively onto the surface of nanoparticles.
“To the best of our knowledge, it is the first time that the interactions of small molecules with pre-formed nanoparticles can be directly measured,” they write in Nature Communications.
Nano cleansing
Even more exciting, they say, is the wide range of potential uses, from environmental remediation to medical analysis.
The polymers are synthesized at room temperature, and don’t need to be specially prepared to target specific compounds; they are broadly applicable to all kinds of hydrophobic chemicals and molecules.
“The interactions we exploit to remove the pollutants are non-specific,” Brandl says. “We can remove hormones, BPA, and pesticides that are all present in the same sample, and we can do this in one step.”
And the nanoparticles’ high surface-area-to-volume ratio means that only a small amount is needed to remove a relatively large quantity of pollutants. The technique could thus offer potential for the cost-effective cleanup of contaminated water and soil on a wider scale.
“From the applied perspective, we showed in a system that the adsorption of small molecules on the surface of the nanoparticles can be used for extraction of any kind,” Bertrand says. “It opens the door for many other applications down the line.”
This approach could possibly be further developed, he speculates, to replace the widespread use of organic solvents for everything from decaffeinating coffee to making paint thinners. Bertrand cites DDT, banned for use as a pesticide in the U.S. since 1972 but still widely used in other parts of the world, as another example of a persistent pollutant that could potentially be remediated using these nanomaterials. “And for analytical applications where you don’t need as much volume to purify or concentrate, this might be interesting,” Bertrand says, offering the example of a cheap testing kit for urine analysis of medical patients.
The study also suggests the broader potential for adapting nanoscale drug-delivery techniques developed for use in environmental remediation.
“That we can apply some of the highly sophisticated, high-precision tools developed for the pharmaceutical industry, and now look at the use of these technologies in broader terms, is phenomenal,” says Frank Gu, an assistant professor of chemical engineering at the University of Waterloo in Canada, and an expert in nanoengineering for health care and medical applications.
“When you think about field deployment, that’s far down the road, but this paper offers a really exciting opportunity to crack a problem that is persistently present,” says Gu, who was not involved in the research. “If you take the normal conventional civil engineering or chemical engineering approach to treating it, it just won’t touch it. That’s where the most exciting part is.”

Fonte: MIT

Australian: Regulatory considerations for nanotechnology for use in agriculture and animal husbandry


Publication of the report Nanotechnologies for pesticides and veterinary medicines: regulatory considerations—final report (July 2015) marks the culmination of four years of APVMA-led research, consultation and collaboration.
The report considers the benefits and challenges of regulating nanotechnology for use in agriculture and animal husbandry, as advances in nanoscale science, engineering and technology pave the way for developing novel applications, devices and systems.
The report aims to inform and stimulate discussion about emerging nanotechnology and highlights the key regulatory considerations for agvet chemical nanomaterials based on the current state of knowledge.
It systematically explores the opportunities and risks of these substances in Australian agriculture and animal husbandry and reviews the published work relevant to the registration of nanoscale agvet chemicals.

Development of the report

In October 2014, the APVMA hosted a symposium on nanotechnology regulation, seeking national and international input from industry, scientists, regulators and the broader community on developing a regulatory framework for nanotechnologies in Australian agriculture and animal husbandry. Discussion was based on the APVMA draft report Regulatory considerations for nanopesticides and veterinary medicines (October 2014), the first of its kind to be made available for public discussion. Input subsequently received was considered in finalising the report.

Next steps

The APVMA will now use the report to finalise the regulatory approach for nanotechnology products, including:
  • building capability and expertise so new products can be evaluated effectively
  • analysing the data requirements
  • enhancing the existing regulatory framework if required as knowledge evolves
  • continuing to engage with the international scientific community so that the latest research is being considered.

Fonte: Australian Governament

Nanossatélite brasileiro parte para o espaço em um mês



O primeiro nanossatélite do Sistema Espacial para Realização de Pesquisas e Experimentos com Nanossatélites, da Agência Espacial Brasileira (AEB) em parceria com universidades, está em Tsukuba, no Japão, para ser integrado ao veículo lançador que vai transportá-lo no dia 16 de agosto para a Estação Espacial Internacional.

O pequeno satélite será colocado em órbita em volta da Terra em outubro. O lançamento será feito pela Jaxa, agência espacial japonesa, pois o Brasil não possui veículo lançador.

No estande da AEB na Expo T&C, uma das principais atrações da 67ª reunião da Sociedade Brasileira para o Progresso da Ciência (SBPC), o estudante de engenharia aeroespacial da Universidade de Brasília (UnB) Brenno Popov apresenta o artefato que ajudou a criar e montar.

Ele afirma que o desafio do projeto é provar a capacidade desses pequenos satélites na transmissão dados, recebendo e devolvendo mensagens que podem ser baixadas de qualquer lugar do planeta.

“Após 30 minutos do lançamento no espaço, o sistema será ligado e as antenas, liberadas, deixando o satélite pronto para receber comunicações da Terra”, explica o estudante.

O modelo de engenharia custou R$ 400 mil. O projeto todo teve o orçamento de R$ 3 milhões, incluindo a locação de equipamentos e modelo de voo. “Como é um satélite universitário, que os estudantes ajudam a desenvolver, não há certeza de que vai funcionar. Mas, por ser uma plataforma barata, de fácil manuseio, se der problema, a perda é pequena”, esclarece Brenno.

Além dos estudantes de Engenharia Aeroespacial e de Engenharia Elétrica da UnB, participaram do projeto alunos das universidades federais de Santa Catarina (UFSC), do ABC (Ufabc), de Minas Gerais (UFMG), do Instituto Federal Fluminense (IFF), e de universidades da Espanha (Universidade de Vigo), dos Estados Unidos (Morehead State University e California State Polytechnic) e da Itália (Sapienza Università di Roma).


*Matéria alterada às 13h19 para corrigir informação. Diferentemente do que foi publicado, o nanossatélite brasileiro só será transportado para a Estação Espacial Internacional no dia 16 de agosto, e não amanhã. O título também foi alterado.

Fonte: EBC

quarta-feira, 22 de julho de 2015

Indústria petroleira busca na nanotecnologia solução para problemas do setor

A demanda mundial por energia pode subir cerca de 60% nos próximos 25 anos, conforme a previsão da Organização dos Países Exportadores de Petróleo (OPEP). Esse índice de crescimento representa um grande desafio para a indústria de combustíveis fósseis. Para atender a esta demanda, as grandes companhias apostam no desenvolvimento e evolução da ciência e da engenharia, especialmente na área de nanotecnologia.
Apenas recentemente tem se constatado avanços no uso da nanotecnologia em áreas chaves da indústria de combustíveis fósseis, como na exploração, monitoramento, refinação e distribuição. Sua utilização é tida como a solução iminente para resolver problemas críticos enfrentados no setor, tanto em relação a extração em localizações remotas (águas muito profundas), condições adversas (altas temperaturas e pressões) e também em reservatórios pouco convencionais, de areia betuminosa, óleos pesados ou gás apertado.

Neste cenário, a nanotecnologia ganha força como uma das principais alternativas para ir além do atual potencial de fornecimento de energia sem deixar de lado a preocupação com as questões ambientais. Por esta razão, a manipulação da matéria numa escala atômica e molecular é apontada como “pedra angular” de toda a energia no futuro, conforme afirma José Vega, articulista no portal venezuelano La Comunidad Petrolera, um dos maiores do segmento na América Latina.

Em alta não apenas na indústria de combustíveis fósseis mas também em diversas outras áreas que movem a economia nacional e internacional, a nanotecnologia faz parte de um mercado mundial que movimenta mais de US$ 100 bilhões, de acordo com a entidade Project on Emerging Nanotechnologies.




domingo, 19 de julho de 2015

Brasil avança em processos de regulação para uso de nanomateriais em medicina diagnóstica e terapêutica

Pesquisador da Universidade de São Paulo, em São Carlos, já registrou 15 patentes na área de nanotecnologia aplicada à melhoria de diagnósticos, terapias e processos regenerativos


O Brasil deu um grande passo em direção à regulação do uso de nanomateriais para diagnóstico, terapia e medicina regenerativa. Desde o ano passado, a partir de uma iniciativa do Ministério da Ciência, Tecnologia e Inovação (MCTI), o país passou a fazer parte da NANoREG, uma plataforma de nanorregulação organizada pela comunidade europeia há três anos, com 16 países participantes, a partir de incentivos da academia e da indústria.
Ao fazer parte da NaNoREG, o Brasil incluiu oito grupos de pesquisa que passam a fazer testes com nanomateriais em laboratórios. “Com a entrada do Brasil, a Anvisa poderá usar as recomendações da NaNoREG”, diz Valtencir Zucolotto, membro afiliado da Academia Brasileira de Ciências (ABC) e professor associado (livre docente) no Instituto de Física de São Carlos – IFSC da Universidade de São Paulo (USP), onde coordena o Grupo de Nanomedicina e Nanotoxicologia GNano/IFSC/USP.

No primeiro dia da 67ª Reunião Anual da SBPC, que acontece na UFSCar, em São Carlos (SP), até 18 de julho, Zucolotto prendeu a atenção de uma plateia formada por pesquisadores e estudantes de diversas áreas ao explicar como o uso de nanomateriais está contribuindo para o avanço da medicina diagnóstica e terapêutica.
De acordo com Zucolotto, o avanço das pesquisas na utilização da nanotecnologia para facilitar diagnósticos, terapias e ampliar os resultados da medicina regenerativa já é uma realidade no Brasil. No âmbito dos diagnósticos, Zucolotto destacou a parceria que o Grupo de Nanomedicina e Nanotoxicologia GNano/IFSC/USP vem desenvolvendo com o Hemocentro de Ribeirão Preto. Ele explicou que começou a produzir nanomateriais para melhorar a qualidade do sistema para detectar células leucêmicas.
“Recobrimos as nanopartículas com uma proteína natural, extraída da jaca, a jacalina”, destacou.
Ainda na área de diagnósticos, ele citou os trabalhos que seu grupo vem desenvolvendo com nanosensores para detectar baixos índices de adiponectina, um hormônio proteico que modula vários processos metabólicos, incluindo a regulação da glicemia e o catabolismo de ácidos graxos. Quando um paciente começa a apresentar quedas nas taxas desse hormônio, ele pode estar prestes a desenvolver um tipo de diabetes.
“Os testes convencionais para detecção desse hormônio são muito caros. A nanotecnologia reduziu esse custo. Quem apresenta uma redução desse hormônio precisa ficar alerta”, ressaltou Zucolotto, que já tem 15 patentes registradas.
Outro trabalho do grupo coordenado por Zucolotto usa sensores com nanoeletrodos para detectar a proteína não-estrutural 1 (NS1), liberada pelo vírus da dengue após a infecção. No âmbito das terapias, o uso de nanomateriais vem contribuindo para o sucesso de smart drug delivery, ou entrega controlada de medicação no corpo do paciente. Zucolotto diz que a técnica vem sendo bem-sucedida, sobretudo, em casos em que é necessário ministrar drogas muito tóxicas, como na quimioterapia.
(Suzana Liskauskas/ Jornal da Ciência)

domingo, 5 de julho de 2015

Can nanotechnology reduce inequality?




RTR3MMLD

This post is part of a series examining the connections between nanotechnology and the top 10 trends facing the world, as described in the Outlook on the Global Agenda 2015. All authors are members of the Global Agenda Council on Nanotechnology.
Over the next decade, nanotechnology will contribute to widespread technological transformation, affecting the productivity and development of a myriad of applications, from new multifunctional materials, to disease diagnostics, water purification and energy efficiency. As it does, there are concerns that it could become a technology of the rich, and help widen social and economic disparities. Yet with the right policies and development culture, nanotechnology can become a global force to reduce inequalities.
Technological innovations like nanotechnology are sometimes seen as increasing social disparities. Technological change, for instance, is often depicted as favouring more skilled workers, replacing tasks previously performed by the unskilled and increasing the demand for skilled labour. In doing so it can create substantial changes in the distribution of wealth nationally and globally. The real picture, however, is much more complex. One could argue that in the globalized world, technology is not an external force acting on the labour market, but an “endogenous” factor, where the conditions and decisions made by the developers, workers, regulators, consumers and exploiters of new technologies can determine use and a fair distribution of the outcome.
Technology and equality can and should go hand in hand. Yet to achieve this, we need creative policies and anticipatory governance mechanisms so that nanotechnology is used to reduce inequality rather than become a new source of it.
From my point of view, as a woman, mother, scientist and educator, the vision is clear and the potential is huge. In the lab, the internationality and multidisciplinarity of nanotechnology empowers our female and male students from all backgrounds, and enhances their scientific and technological creativity and entrepreneurship. Many of the applications of nanotechnology we and others are working on are potentially cheap and easy to implement, requiring minimum lab infrastructure. With the right framework, nanotechnology could become a global force to reduce national and global inequalities.
Take Elizabeth Holmes, who founded Theranos when she was 19. She uses nanoparticles to increase the effectiveness of blood testing at a fraction of current costs.Her motivation is “to create a new technology, and one that is aimed at helping humanity at all levels, regardless of geography or ethnicity or age or gender”. Elizabeth envisions empowered patients who can take control of their health through real-time diagnosis and monitoring, with testing that has open and transparent pricing schemes. The fusion of technology and inequality reduction is at the heart of her mission. She has also become the world’s youngest female self-made billionaire.
Beckers_Hospital_Blood_infographic
In a very different context, a group of scientists led by Marianny Y. Combariza and Cristian Blanco-Tirado at the Industrial University of Santander, in Bucaramanga, Colombia, have developed a method to synthesize nanoparticles directly on the fibres of fique. Fique is extracted from Colombiancabuya, which is mainly used in the fabrication of sacks for transporting Colombian coffee. This nano-enhanced traditional material can be used in the remediation of water contaminated with toxic indigo, which is currently used as a dye in the fabrication of denim in the region.
This example in particular illustrates how scientists are able to find relatively simple and cheap solutions to local challenges using community-relevant nanotechnology and local resources. These researchers are now pursuing the commercialization of their product globally through a partnership with ISIS innovation in the UK. It’s an example of how state-funded research and education, and public-private partnerships, can encourage wealth creation from the local entrepreneurs.
As a third example, Askwar Hilonga has developed a customizable water filter based on sand and nanomaterials, that can be tuned for water decontamination and disinfection in different environments.  Through the Gongali Model Company, a university spin-off company which he co-founded in Tanzania, Hilonga has already enabled 23 entrepreneurs in Karatu to set up their businesses with the filters, and local schools to provide their learners with clean drinking water. As Hilonga states: “Our success will not be in the sales of the filters only. We’re planning on turning community centres into ‘water hubs’. Here water can be purified and families will be able to access clean filtered water at a cheap price.”
As nanotechnology matures, we have an opportunity to develop and promote policies and approaches that reduce inequalities within the culture of sustainable developmentthat is embedded in the DNA of our field.
For instance:
  1. Policies for developing technology should include creativity, inclusiveness and equality within their core values.
  2. Public-private partnerships on both exploratory and late-stage research are needed to promote application development, qualification, regulation and adoption, facilitating the translation and the scale-up of products and ideas.
  3. The growth of existing activities should be supported through regulation that encourages local social and economic entrepreneurship and equality, rather than aligning with and protecting existing (more or less successful) economic activities.
  4. To stop the drain of talent (especially of women) and ideas that we currently suffer in academia and business in science, technology and engineering, stronger policies and actions that underpin diversity and equity are needed.
  5. We need to incentivize good practice in academia and business by, for instance, creating charters and awards that highlight and reward equitable progress and inclusiveness.
  6. We need to do a better job of including equality, diversity and entrepreneurship in parameters used to rank academic institutions globally.
  7. We need to create ambitious international scholarships and educational programmes with a strong emphasis on equality within nanotechnology, where students are encouraged to move, network, learn, disseminate and start businesses, and where institutions and industry can find a tangible value in promoting equality.
Nanotechnology is not only a large group of scientists dealing with very small things: it is a conscious, international, responsible community that has all the ingredients to become a force for social and economic equality. With the right policies, we have the opportunity to make this potential a reality.
Publication does not imply endorsement of views by the World Economic Forum.
Author: Sonia Contera is Co-Director of the Institute of Nanoscience for Medicine at Oxford Martin School, University of Oxford
Image: Physicist Urs Duerig uses tweezers to hold a silicon tip with a sharp apex, 100,000 times smaller than a sharpened pencil. REUTERS/Arnd Wiegmann 
Fonte: Agenda